Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation  by Lamb, Hildo J et al.
Studies Following Cardiac Surgery
Left Ventricular Remodeling
Early After Aortic Valve Replacement:
Differential Effects on Diastolic Function in
Aortic Valve Stenosis and Aortic Regurgitation
Hildo J. Lamb, PHD,* Hugo P. Beyerbacht, MD,† Albert de Roos, MD,* Arnoud van der Laarse, PHD,†
Hubert W. Vliegen, MD,† Ferre Leujes, MD,† Jeroen J. Bax, MD,† Ernst E. van der Wall, MD†
Leiden, The Netherlands
OBJECTIVES The aim of this study was to evaluate the effect of aortic valve replacement (AVR) on left
ventricular (LV) function and LV remodeling, comparing patients with aortic valve stenosis
to patients with aortic regurgitation.
BACKGROUND Aortic valve disease is associated with eccentric or concentric LV hypertrophy and changes in
LV function. The relationship between LV geometry and LV function and the effect of LV
remodeling after AVR on diastolic filling, in patients with aortic valve stenosis compared with
aortic regurgitation, are largely unknown.
METHODS Nineteen patients with aortic valve disease (12 aortic valve stenosis, 7 aortic regurgitation)
were studied using magnetic resonance imaging to assess LV geometry and LV function
before and 9  3 months after AVR. Ten age-matched healthy males served as control
subjects.
RESULTS Before AVR, the ratio between left ventricular mass index (LVMI) and left ventricular
end-diastolic volume index (LVEDVI) was only increased in patients with aortic valve
stenosis (1.37  0.16 g/ml) compared with control subjects (0.93  0.08 g/ml, p  0.05).
After AVR, LVMI/LVEDVI decreased significantly in aortic valve stenosis (to 1.15 
0.14 g/ml, p  0.0001), but increased significantly in aortic regurgitation (1.02  0.20 g/ml
to 1.44  0.27 g/ml, p  0.0001). Before AVR, diastolic filling was impaired in both aortic
valve stenosis and aortic regurgitation. Early after AVR, diastolic filling improved in patients
with aortic valve stenosis, whereas patients with aortic regurgitation showed a deterioration
in diastolic filling.
CONCLUSIONS Early after AVR, patients with aortic valve stenosis show a decrease in both LVMI and
LVMI/LVEDVI and an improvement in diastolic filling, whereas in patients with aortic
regurgitation, LVMI decreases less rapidly than LVEDVI, causing concentric remodeling of
the LV, most likely explaining the observed deterioration of diastolic filling in these
patients. (J Am Coll Cardiol 2002;40:2182–8) © 2002 by the American College of
Cardiology Foundation
Patients with aortic valve stenosis and/or aortic regurgita-
tion are subjected to increased pressure and/or volume load
of the left ventricle, leading to either concentric or eccentric
left ventricular hypertrophy (LVH) (1–3). Left ventricular
hypertrophy is a recognized risk factor for cardiac morbidity
and mortality (4) and is associated with systolic and/or
diastolic function disturbances (5–13). In patients with
aortic valve disease, diastolic and systolic function distur-
bances have important implications for morbidity and mor-
tality before and after aortic valve replacement (AVR)
(3,5,12–15). A previous study using left ventricular (LV)
bi-plane angiography and high-fidelity pressure measure-
ments has shown that diastolic function of patients with
aortic valve stenosis deteriorates immediately after AVR. At
follow-up, diastolic function improves gradually and may
normalize completely long after AVR (13). The effect of
AVR on diastolic function in patients with aortic regurgi-
tation has not been studied extensively.
The LV geometrical shape also influences the outcome of
AVR (3,14–18). Previous studies have focused on the
postoperative regression of LV mass or LV volume
(1,3,19,20). The relationship between LV remodeling and
changes in LV diastolic filling properties after AVR and the
differences between these changes in patients with aortic
valve stenosis compared with patients with aortic regurgi-
tation have not been studied previously.
Magnetic resonance (MR) imaging is a noninvasive,
highly reproducible method for accurate measurement of
LV mass and LV volume without the use of geometric
assumptions (21–24). Magnetic resonance phase contrast
flow velocity mapping allows measurement of flow-velocity
as well as flow-volumes across the mitral valve orifice,
providing a new means of diastolic function assessment
which may even be a more sensitive method than Doppler
From the Departments of *Radiology and †Cardiology, Leiden University Medical
Center, Leiden, The Netherlands.
Manuscript received March 6, 2002; revised manuscript received August 16, 2002,
accepted September 6, 2002.
Journal of the American College of Cardiology Vol. 40, No. 12, 2002
© 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00
Published by Elsevier Science Inc. PII S0735-1097(02)02604-9
echocardiography (25–27). The superior image quality and
accuracy of MR imaging compared with echocardiography
(21–24) has never been used to assess LV remodeling after
AVR and to correlate the observed geometric changes to LV
diastolic function. Therefore, the purpose of the present
study was to assess the relationship between LV geometry
and LV diastolic function in patients with either severe
aortic valve stenosis or severe aortic regurgitation, before
and early after AVR, using MR imaging.
METHODS
Study population. Nineteen patients (15 males, 4 females)
with severe aortic valve disease and without significant
coronary artery disease at cardiac catheterization were stud-
ied with MR imaging within a period of four weeks before
aortic valve surgery. The baseline characteristics of patients
and control subjects are listed in Table 1. Twelve patients
had predominantly aortic valve stenosis with a peak-to-peak
pressure gradient across the aortic valve of at least 60 mm
Hg (mean 87.8  22.6 mm Hg) without hemodynam-
ically significant aortic regurgitation (grade 1 or 2; mean
grade 1.1  1.0). Seven patients had predominantly aortic
regurgitation (grade 3 or 4, mean grade 3.9  0.4) and a
peak-to-peak pressure gradient across the aortic valve of
60 mm Hg (mean 22.6  28.0 mm Hg). The MR
imaging was repeated 9  3 months after AVR in all 19
patients. A group of 10 healthy, age-matched males served
as control subjects; they were normal at physical examina-
tion, had a normal electrocardiogram at rest and during
exercise stress testing, and had no history of cardiac or any
other major illness. The protocol was approved by the
hospital’s Human Research Committee. All subjects gave
informed consent before investigation.
MR image acquisition. Magnetic resonance imaging was
performed on a 1.5-T ACS-NT15 system (Philips Medical
Systems, Best, The Netherlands) using prospective electro-
cardiographic triggering. A stack of short-axis images con-
sisting of 10 to 12 slices (depending on heart size), with a
thickness of 8 mm and an intersection gap of 1 mm was
acquired using breath hold multishot echo planar imaging.
Images encompassed the entire left ventricle. The imaging
protocol was similar as reported previously (23).
Phase contrast flow velocity measurements across the
mitral valve orifice were acquired using a gradient echo
acquisition sequence with retrospective gating. Velocity
maps were acquired across the mitral orifice using a flip
angle of 20° and an echo time of 10 to 12 ms. The image
section had a thickness of 8 mm, a field of view of 350 mm,
and consisted of two measurements of a 128  128
acquisition matrix which was interpolated to a display
matrix of 256  256 pixels. Depending on the actual heart
rate, between 30 and 45 time frames were evenly distributed
over the cardiac cycle, resulting in a temporal resolution of
25 to 30 ms. Total acquisition time was about 3 min. The
maximum phase shift of 180° was set to occur at a velocity
of 100 cm/s.
MR image analysis. The MR images and velocity maps
were analyzed on a remote workstation (Sun Microsystems
Computer Corp., Mountain View, California). The LV
short-axis acquisitions were used to assess LV dimensions,
wall mass, ejection fraction, and cardiac output (CO). The
endocardial, epicardial, and papillary muscle borders of the
end-diastolic and end-systolic images from each short-axis
slice were manually traced using the MR analytical software
system developed at this institution (22). Measurements
were performed on separate occasions by two independent
experienced observers. Reported data represent the average
value from both observers. Myocardial borders were de-
tected in the same way as previously reported, with an
intraobserver and interobserver variability of 4  2% and
9  3%, respectively (27). The left ventricular mass index
(LVMI), left ventricular end-diastolic volume index
(LVEDVI), CO, and left ventricular ejection fraction
(LVEF) were calculated as described before (23). The ratio
Abbreviations and Acronyms
AVR  aortic valve replacement
CO  cardiac output
E  early diastolic filling
LV  left ventricular
LVEDVI  left ventricular end-diastolic volume index
LVEF  left ventricular ejection fraction
LVH  left ventricular hypertrophy
LVMI  left ventricular mass index
MR  magnetic resonance
Table 1. Patient Characteristics Before Aortic Valve Replacement and Characteristics of Control
Subjects
Aortic Valve Stenosis
(n  12)
Aortic Regurgitation
(n  7)
Controls
(n  10)
Age (yrs) 54.8  13.7 61.6  5.4 60.2  3.9
BSA (m2) 1.88  0.16 1.87  0.15 1.90  0.17
SBP (mm Hg) 113.4  14.6 129.1  27.0 115.5  9.2
DBP (mm Hg) 69.1  8.7 61.9  7.3 70.5  4.6
Heart rate (beats/min) 70.1  17.0 69.9  8.4 65.3  11.9
Pressure gradient (mm Hg) 87.8  22.6 22.1  28.0* n.a.
Regurgitation grade 1.08  1.00 3.86  0.38* n.a.
*p  0.001 aortic stenosis versus aortic regurgitation (two-sample two-tailed t test).
BSA  body surface area; DBP  diastolic blood pressure; n.a.  not applicable; SBP  systolic blood pressure.
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of LVMI and LVEDVI (LVMI/LVEDVI) was used as an
indicator of LVMI normalized to chamber size. The clas-
sification in concentric or eccentric hypertrophy was based
on comparison of patients with the control group: a statis-
tically significant increase in LVMI, LVEDVI, and LVMI/
LVEDVI is concentric hypertrophy, but a nonstatistically
significant difference in LVMI/LVEDVI is eccentric hy-
pertrophy.
Volumetric flow across the mitral valve was calculated by
manually tracing the borders of the mitral valve in all time
frames of the velocity map series, using the FLOW analyt-
ical software package (MEDIS Medical Imaging Systems,
Leiden, The Netherlands) (28). Contour tracings were
performed on two occasions by a different observer. Flow
curves were automatically analyzed following a manual
indication of the start of early (E) filling, peak E filling, peak
atrial (A) contribution to filling, and the end of filling as
described previously (26). To correct for differences in
stroke volume and/or heart rate, the E-wave acceleration
and deceleration slopes were also normalized for CO.
Statistical analysis. Reported data are expressed as mean
values  1 SD. When applicable, paired two-tailed Student
t tests were used, otherwise two-sample two-tailed Student
t tests were used. A p value of 0.05 was considered
statistically significant. Correlations were determined using
linear regression analysis.
RESULTS
LV geometry. All patients with aortic stenosis exhibited an
improvement in symptoms directly after surgery. In con-
trast, only three of seven patients with aortic regurgitation
improved in symptoms after the procedure. Finally, in this
cohort of patients perioperative mortality was 0% and
in-hospital mortality was also 0%. Peripheral systolic and
diastolic blood pressures and heart rate did not change
significantly after surgery, changing to 127.1  14.9 mm
Hg, 74.8  7.0 mm Hg, and 66.1  10.4 beats/min
respectively for patients with aortic valve stenosis, and to
121.2 25.0 mm Hg, 65.9 9.8 mm Hg, and 65.6 12.9
beats/min respectively for patients with aortic regurgitation
(all p  0.05, see Table 1 for baseline characteristics). The
results of all 19 patients regarding LV function and LV
geometry before and after AVR are summarized in Table 2,
together with the corresponding data obtained in 10
control subjects. In 12 patients with aortic valve stenosis,
LVMI decreased from 126.3  33.1 g/m2 to postopera-
tively 87.5  23.6 g/m2 (p  0.0001), and in 7 patients
with aortic regurgitation, LVMI decreased from 146.5 
38.2 g/m2 to postoperatively 119.1  29.0 g/m2 (p  0.05).
In both groups of patients, LVMI after surgery was still
significantly higher than LVMI in control subjects (68.6 
7.9 g/m2, p  0.05). After surgery, LVMI was significantly
higher in patients with aortic regurgitation than in patients
with aortic valve stenosis (p  0.05).
The changes in LV geometry after AVR were also
assessed by calculation of the changes in LVMI/LVEDVI
and are presented in Figure 1. Patients with aortic valve
stenosis had concentric LVH, as compared with patients
with aortic regurgitation and compared with control
subjects. The LVMI/LVEDVI in control subjects was
0.93  0.08 g/ml. Before surgery, this ratio in patients with
aortic regurgitation was within the normal range (1.02 
0.20 g/ml), but it was elevated in patients with aortic valve
stenosis (1.37  0.16 g/ml, p  0.001 vs. control subjects
and vs. aortic regurgitation). After surgery, LVMI/
LVEDVI in patients with aortic regurgitation increased
from 1.02  0.20 g/ml to 1.44  0.27 g/ml (p  0.0001),
whereas in patients with aortic valve stenosis LVMI/
LVEDVI decreased from 1.37  0.16 g/ml to 1.15 
0.14 g/ml (p  0.0001).
LV function. Before AVR, ejection fraction was not
changed in patients compared with control subjects; LVEF
was 60.2  13.2% in patients with aortic valve stenosis,
53.2  10.7% in patients with aortic regurgitation, and
59.0  4.3% in control subjects (p  NS). After AVR,
LVEF was significantly higher in patients with aortic valve
stenosis than in patients with aortic regurgitation (62.9 
5.2% vs. 53.0  8.7%, p  0.01).
Table 2. LV Function and Geometry Before and After Aortic Valve Replacement Compared With Control Subjects
Control
Subjects
(n  10)
Aortic Valve
Stenosis Pre
(n  12)
Aortic Valve
Stenosis Post
(n  12)
Aortic
Regurgitation Pre
(n  7)
Aortic
Regurgitation Post
(n  7)
LVMI (gm2) 68.6  7.9 126.3  33.1* 87.5  23.6*†‡ 146.5  38.2* 119.1  29.0*†‡
LVMI/LVEDVI (gml1) 0.93  0.08 1.37  0.16*‡ 1.14  0.14*†‡ 1.02  0.22‡ 1.44  0.27*†‡
LVEDVI (mlm2) 74.2  8.0 92.0  19.8*‡ 76.7  20.1† 149.1  47.7*‡ 86.5  27.8†
Cardiac output (Lmin1) 5.44  1.29 6.96  1.95*‡ 6.18  2.16 9.53  3.25*‡ 6.59  2.35†
LV ejection fraction (%) 59.0  4.3 60.2  13.2 62.9  5.2‡ 53.2  10.7 53.1  8.8‡
E/A peak 1.18  0.39 1.40  0.88 1.34  0.60 1.74  1.33 1.00  0.70
E accel peak (mls2)103 6.76  1.48 5.22  1.90‡ 6.36  2.58‡ 7.54  2.46†‡ 3.49  1.83*‡
E accel peak/CO (s1)103 0.081  0.033 0.046  0.017* 0.063  0.0190†‡ 0.048  0.008* 0.032  0.012*†‡
E decel peak (mls2)103 3.47  0.87 2.59  1.31‡ 3.13  1.86 4.11  1.64‡ 1.58  0.84*†
E decel peak/CO (s1)103 0.042  0.020 0.024  0.017* 0.030  0.015‡ 0.026  0.008 0.015  0.006*†‡
A mean accel (mls2)103 4.96  0.90 2.99  1.54* 3.70  0.98* 3.44  2.13 3.08  1.74*
*p  0.05 versus controls; †p  0.05 before surgery versus after surgery (paired two-tailed t test); ‡p  0.05 aortic stenosis versus aortic regurgitation (pre vs. pre or post vs. post).
A  atrial contribution to diastolic filling; CO  cardiac output; decel  deceleration; E  early diastolic filling; E accel peak  maximum acceleration slope during early
diastolic filling; EDVI  end-diastolic volume index; LV  left ventricular; MI  mass index; post  after valve replacement; pre  before valve replacement.
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Before AVR, diastolic function was impaired in both
groups of patients. For example, the E-wave acceleration
peak normalized for CO was lower in patients with aortic
valve stenosis and aortic regurgitation (0.046 0.017 s1
103 and 0.048  0.008 s1  103, respectively) than in
control subjects (0.081  0.033 s1  103). In patients
with aortic valve stenosis, E-wave acceleration peak and
deceleration peak slopes normalized for CO improved after
AVR, whereas these parameters deteriorated postopera-
tively in patients with aortic regurgitation (Fig. 2, Table 2).
Correlation between LV geometry and LV function.
From the data obtained in all 19 preoperative patients and
in 10 control subjects, we investigated whether LV geom-
etry and LV function parameters were correlated. To that
purpose, baseline LVMI, LVMI/LVEDVI, and LVEDVI
were correlated to selected baseline functional parameters. A
significant correlation was observed between LVMI and
E-wave acceleration (r0.49, p 0.01) and deceleration
(r  0.45, p  0.05) slopes after normalization for CO. A
good correlation was also found between LVMI/LVEDVI
and E-wave acceleration and deceleration slopes after nor-
malization for CO (r  0.50 and r  0.47 respectively,
p  0.01). The E/A peak did not correlate significantly to
LVMI, nor to LVMI/LVEDVI (r  0.12 and r  0.31,
respectively, p  NS).
DISCUSSION
LV geometry. Before AVR, we found that patients with
aortic valve stenosis had typical concentric LVH, because
their LVMI and LVMI/LVEDVI were significantly higher
than those of control subjects. After surgery, with relief of
pressure overload, LVMI and LVMI/LVEDVI decreased
significantly towards values observed in control subjects.
However, in patients with aortic regurgitation, preoperative
LVMI was significantly increased but LVMI/LVEDVI was
comparable to the values in control subjects. After AVR, in
these patients LVMI decreased less rapidly than LVEDVI,
causing an increase in LVMI/LVEDVI. As a result, these
patients showed concentric remodeling of the LV.
Our findings are in agreement with Carroll et al. (17)
who found that in most patients with aortic regurgitation
LV end-diastolic dimensions and volumes became near
normal within two weeks after AVR, whereas a significant
regression of LVH took at least six months. However, other
studies have shown that several patients with aortic regur-
gitation who had a severely depressed LVEF and a strongly
dilated LV before surgery, failed to achieve regression of
LVH after AVR (29,30). These studies also recognized
relative wall thickness as an important prognostic parameter
in patients with aortic regurgitation (3,29,30).
An increase in LV wall thickness proportional to the
increase in LV radius preserves LV systolic wall stress and
can prevent irreversible cardiac dilation and failure (3). In
patients with aortic valve stenosis, the presence of a super-
normal ejection fraction and “disproportionally high” rela-
tive wall thickness before AVR is associated with an
excessive perioperative risk of morbidity and mortality
(2,15,16). Alternatively, aortic valve stenosis patients with a
low relative wall thickness and eccentric hypertrophy
showed decreased systolic function as well as symptoms of
heart failure (18). The clinical implications associated with
the contrasting changes in LVMI/LVEDVI after AVR in
patients with aortic valve stenosis compared with patients
with aortic regurgitation, as observed in the present study,
Figure 1. The left ventricular mass index (LVMI)/left ventricular end-diastolic volume index (LVEDVI) of 12 patients with aortic valve stenosis and 7
patients with aortic regurgitation, before (PRE) and after (POST) valve replacement, compared with 10 control subjects. Mean values are displayed with
standard deviation bars. *p  0.05 versus control subjects; †p  0.05 before surgery versus after surgery (paired two-tailed t test); ‡p  0.05 aortic stenosis
versus aortic regurgitation (pre vs. pre or post vs. post).
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merit future investigation. In the present study, follow-up
was relatively short (9 3 months) and only associated with
partial regression of LVMI. Complete regression of LVH
may take many years (1,3,13,19,20), but it is important
because incomplete regression of LVH after AVR is also
associated with decreased survival (29).
Diastolic function. Before AVR, all patients with aortic
valve disease demonstrated abnormal diastolic filling, result-
ing from impaired LV relaxation, increased chamber stiff-
ness, and/or chamber dilation (11,31,32). After AVR, in
patients with aortic valve stenosis, LV geometry and dia-
stolic properties both showed a trend towards normaliza-
tion, illustrated by a decrease in both LVMI and LVMI/
LVEDVI and an increase of the E-wave acceleration peak
and deceleration peak normalized for CO (Table 2, Figs. 1
and 2). However, in patients with aortic regurgitation, the
decline of LVEDVI after AVR occurs faster than normal-
ization of LVMI, resulting in concentric remodeling. Con-
centric LVH is associated with impaired LV relaxation and
increased chamber stiffness (5–10,31) and, therefore, may
have contributed to the observed worsening of diastolic
filling parameters illustrated by a decrease of the E-wave
acceleration peak and deceleration peak normalized for CO
in patients with aortic regurgitation after AVR. The de-
crease of the E-wave deceleration peak normalized for CO
in patients with aortic regurgitation after AVR is probably
largely due to a reduction in left atrial pressure.
The importance of assessment of diastolic function before
aortic valve surgery was underlined by two studies of Lund
et al. (12,33) who found that impaired diastolic function in
Figure 2. (A) The maximum acceleration slope of early diastolic filling corrected for cardiac output (E accel peak/CO), and (B) the maximum deceleration
slope of early diastolic filling corrected for cardiac output (E decel peak/CO) of 12 patients with aortic valve stenosis and 7 patients with aortic regurgitation,
before (PRE) valve replacement and 9 3 months after (POST) valve replacement, compared with 10 control subjects. The mean values are displayed with
standard deviation bars. *p  0.05 versus control subjects; †p  0.05 before surgery versus after surgery (paired two-tailed t test); ‡p  0.05 aortic stenosis
versus aortic regurgitation (pre vs. pre or post vs. post).
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patients with aortic valve stenosis is associated with in-
creased mortality in the period before AVR, and is an
independent risk factor for early and late postoperative
mortality. Other studies have addressed the early and late
changes in diastolic function after AVR, both in patients
with aortic valve stenosis and in patients with aortic regur-
gitation (5,8,10,13,14). Patients with aortic valve stenosis
had increased diastolic stiffness early after AVR, parallel to
the relative increase in interstitial fibrosis (13). Moreover,
diastolic stiffness and relaxation normalized late (81  24
months) after AVR owing to regression of both muscular
and nonmuscular tissue. Relaxation was correlated to the
extent of hypertrophy, whereas passive elastic properties
were correlated to changes in nonmuscular tissue (13).
In the present study, MR phase contrast flow velocity
mapping was used to assess diastolic function. The studied
groups represented a wide range of LV sizes and corre-
sponding stroke volumes. Usually, the shape of the LV
filling curve is influenced by LV relaxation, left atrial
pressure, elastic properties of the LV, but also by stroke
volume, ventricular size, and heart rate (11,31,32). Mirsky
(34) suggested inclusion of LV volume in the chamber
stiffness-pressure relationship and introduced the term “vol-
ume elasticity.” To follow the concept of volume elasticity,
we normalized the E acceleration peak and E deceleration
peak for CO. As demonstrated in Table 2, the differences in
diastolic properties of the LV between patients and control
subjects, but also between aortic valve stenosis and aortic
regurgitation patients, only became fully apparent after
normalization of early diastolic filling (E) for CO.
Ejection fraction. Ejection fraction was largely unaffected
in the present group of patients with severe aortic valve
disease. Before and after AVR, LVEF was slightly lower in
patients with aortic regurgitation compared with both
control subjects and patients with aortic valve stenosis,
although LVEF differed significantly only between postop-
erative patients with aortic valve stenosis and postoperative
patients with aortic regurgitation. These findings confirm
that diastolic function in aortic valve disease is affected at an
earlier stage of the disease process than the ejection fraction.
Therefore, deterioration of the ejection fraction should be
considered as a sign of severe and advanced aortic valve
disease (12,14).
Correlation between LV geometry and LV diastolic
function. Increased LVMI and increased LVMI/LVEDVI
were negatively correlated to the E acceleration peak nor-
malized for CO. The acceleration peak of E is influenced by
several determinants such as left atrial pressure, the LV
relaxation constant, LV end-systolic volume, LV systolic
function, and intrinsic myocardial stiffness (11,31,32). In
patients with aortic valve stenosis before AVR, the de-
pressed E acceleration peak is due to prolonged LV relax-
ation and increased myocardial stiffness (31). After surgery,
LVMI and LVMI/LVEDVI both decreased, whereas the E
acceleration peak increased, the latter largely due to im-
proved myocardial relaxation and reduced myocardial stiff-
ness (31). In patients with aortic regurgitation before AVR,
the depressed E acceleration peak slope results from pro-
longed LV relaxation and increased myocardial stiffness
(11,31,32). After surgery, LVMI decreased but LVMI/
LVEDVI increased, leading to concentric remodeling. The
further decrease of the E acceleration peak slope is most
likely caused by a reduced left atrial pressure combined with
a prolongation of myocardial relaxation and increment of
myocardial stiffness (31).
The LVMI and LVMI/LVEDVI were positively corre-
lated to the E deceleration peak normalized for CO.
Concentric LVH increases intrinsic myocardial stiffness and
is known to shorten the deceleration time and to increase
the deceleration peak of E (11,31,32). In patients with
aortic valve stenosis before AVR, the depressed E deceler-
ation peak slope, therefore, is due to prolonged LV relax-
ation (11,31). After surgery, LVMI and LVMI/LVEDVI
both decreased, whereas the E deceleration peak slope
increased, most likely as a result of improved myocardial
relaxation (31).
In patients with aortic regurgitation before AVR, the
depressed E deceleration peak also results from prolonged
LV relaxation (31). After surgery, LVMI decreased but
LVMI/LVEDVI increased, leading to concentric remodel-
ing. The further decrease of the E deceleration peak slope
after AVR, therefore, is mainly caused by a reduction of left
atrial filling pressure and a prolongation of myocardial
relaxation (11,31,32).
Study limitations. Patient follow-up after surgery was
performed at 9  3 months, so early and late effects of
surgery are mixed. Thus, changes in morphology and
function are not completely uniform, which is reflected by
the reported standard deviations.
The clinical definition for concentric and eccentric hy-
pertrophy or remodeling, as described in the present study,
may be different from the pathophysiologic definition. The
main difference is that with the currently applied imaging
technique it is not possible to evaluate sarcomere orienta-
tion. Therefore, the parallel sarcomere deposition in con-
centric hypertrophy cannot be discriminated from the serial
deposition in eccentric hypertrophy.
In the present study, it was not clinically feasible to
measure invasive left atrial pressures. Therefore, on the basis
of previous reports, we only speculate on the effects of
changes in left atrial pressures on diastolic filling character-
istics.
CONCLUSIONS
Patients with aortic valve stenosis or patients with aortic
regurgitation show a differential response in diastolic func-
tion early after AVR. Before AVR, patients with aortic valve
stenosis show concentric LVH. Early after AVR, both
LVMI and LVMI/LVEDVI decrease and diastolic filling
improves. In patients with aortic regurgitation, preoperative
LVMI and LVEDVI are about equally increased, resulting
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in a LVMI/LVEDVI within the normal range. Early after
AVR, LVMI decreases less rapidly than LVEDVI, causing
an increase in LVMI/LVEDVI. Despite the absolute de-
crease in LVMI, these patients at least temporarily show
concentric remodeling of the LV, most likely explaining the
observed deterioration of diastolic filling in these patients.
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